NUCB2 and prostate cancer: Accumulating evidence has indicated that NUCB2/nesfatin‐1 expression was upregulated in cancer tissues compared to the noncancerous tissues obtained from the same patient in various tumours including colon cancer,10 prostate cancer,19 endometrial cancer11 and papillary thyroid cancer.12